Carregant...
Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR
Objective: To investigate the reversal effect of tuberostemonine on MDR in myelogenous leukemia cells K562/ADR. Methods: Human myelogenous leukemia cells K562 and their adriamycin-resistance cells K562/ADR were used. The growth curve of cells treated by tuberostemonine and the Non-toxic concentratio...
Guardat en:
| Publicat a: | J Cancer |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ivyspring International Publisher
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5436265/ https://ncbi.nlm.nih.gov/pubmed/28529625 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.17688 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|